ASIPP 21
st
Annual Meeting Tremendous Success
|
|
The ASIPP 21
st
Annual Meeting, held May 3-5, 2019 in Las Vegas was a tremendous success! With more than 900 participants attending last week’s Las Vegas meeting, members were both enlightened and educated by the experience.
Highlights of the meeting included many top notch speakers, an awards ceremony, a wide variety of break out sessions, and
70 plus booth in the exhibit hall.
The 2019-2020 Board of Directors was installed during the meeting with Dr. Hans Hansen passing the president’s gavel to Dr. Sudhir Diwan
Distinguished and keynote speakers include:
Raj-Racz Distinguished Lecture Series
John J. Nance, and Laxmaiah Manchikanti, MD
,
Keynote Speakers
Linda Watkins, PhD, Matt Andry, MD, Devi Nampiaparampil, MD, and Scott Grubman, Esq
Manchikanti Distinguished Lecture Series
Robert Laszewski
, and
Sanjeeva Gupta, MD
The Awards Ceremony Saturday recognized those who have contributed to the speciality in very meaningful ways. Winners and awards were:
Lifetime Achievement Award: Standiford Helm, MD, and Andrea Trescot, MD
Racz Excellence Award: Larry Driver, MD
Raj Excellence Award: Miles Day, MD
Manchikanti Excellence Award: Sairam Atluri, MD
International Award: Sanjeeva Gupta, MD
Distinguished Service: Sheri Albers, DO, Sheldon Jordan, MD , Joseph Cabaret, MD,
and Ramarao Pasupuleti, MD
Outstanding Research: Ricardo Vallejo, MD, PhD, and Amol Soin, MD
Rising Star: Michael Lubrano, MD
Outstanding State Society: FSIPP, NYSIPP, NJSIPP, OHSIPP, WVSIPP, GSIPP
Outstanding Advocacy: Ramsin Benyamin, MD, Dharam Mann, Mahendra Sanapati, MD
Deborah Tracy, MD
Academic Achievement: Nick Knezevic, MD, PhD, and Joshua Hirsch, MD
Outstanding Journalism: Devi Nampiaparampil, MD
Social Media Champion: Hans Hansen, MD
Top Abstracts:
Resident/Fellow section
1
st Mark Jones and Vwaire Orhurhu
2nd Ajex Yang
3
rd Saiyun Hou
Physician section
1st Navdeep Jassal
2
nd Ricardo Vallejo
3
rd Corey Hunger
Make plans right now to attend next year’s meeting in Dallas, Texas!
Meeting dates are April 2-4, 2020.
|
|
JULY ABIPP EXAMS
AND COMPETENCY EXAMS
July 13 - July 14 | Memphis, TN
The
American Board of Interventional Pain Physicians
(
ABIPP
)
has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management
profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become
ABIPP
certified.
Register
May1 to May 15, 2019, fee is $2,000
May 16 to May 30, fee is total of $3,000
No registrations after May 30.
ABIPP
now offers the only competency
certification program for regenerative medicine.
For complete information about the examination requirements and to obtain an application packet, visit www.abipp.org or call 270-554-9412 x4217 or by email at summer@asipp.org.
July 13
ABIPP Part I
July 13
ABIPP Part I
July 13-14
ABIPP Part II
July 14
ABIPP Competency Exam
July 13
Combined CSM/CCPM Exam for ABIPP Path
July 13
Competency Exam in Controlled Substance Management
July 13
Competency Exam in Coding, Compliance, and
Practice Management
July 13-14
Regenerative Medicine Competency Exam
July 13-14
Endoscopic Lumbar Decompression Competency Exam
939 Ridge Lake Blvd. | Memphis, TN 38120
The cut-off date for our room block with discounted rates is on June 10, 2019 or until sold out, whichever occurs first.
|
|
National Spine & Pain Centers involved in $3.3M settlement over fraud allegations: 3 key details
Three key details:
1. Both organizations operate pain management clinics in northern Virginia, Fredericksburg, Va., and Glen Allen, Va. They are accused of billing for medical services as if they were provided by physicians, when they were actually performed by physician assistants and nurse practitioners.
2. The pain clinics also ordered medically unnecessary urine drug tests and submitted illegal claims for those services, according to federal prosecutors.
|
|
Nearly half of physicians think EHRs have decreased quality of care, survey finds
More physicians (44 percent) believe that EHRs have hurt quality of care in their workplace than the 40 percent who said the technology has improved it, according to a recent
Medscape poll
released May 1.
Medscape surveyed 273 U.S. clinicians — 207 physicians and 66 nurses and advanced practice registered nurses — for the poll.
A former physician assistant at Physical Medicine Associates filed the lawsuit under the whistleblower provisions of the False Claims Act. The whistleblower will be awarded up to 25 percent of the settlement.
|
|
‘Pill mill’ doctor who lost license three times is sentenced to seven years in prison
A doctor with a history of misconduct who lost his medical license three times was sentenced to seven years in prison Friday for running a clinic that prescribed opioids with little evaluation or oversight.
Shriharsh Pole, 65, pleaded guilty in federal court in Alexandria last year to a drug distribution conspiracy.
“I realize my mistake, and I sincerely apologize for it,” he told U.S. District Judge Claude M. Hilton. “It was a lack of judgment on my part.”
Access to this article may be limited.
|
|
Octogenarian Manhattan doctor accused of prescribing 2 million pills gets 20-year prison term for patient’s deadly opioid overdose
There was no sympathy for this drug-dispensing devil.
An octogenarian doctor whose illegal opioid prescriptions killed a 27-year-old patient was sentenced Tuesday to 20 years in federal prison for his wanton distribution of the deadly pills — an almost-guaranteed life term for the frail physician.
>Dr. Martin Tesher, 83, of Manhattan, is a pill-pushing animal, said Krystal Benedetto, who found the lifeless body of her brother Nicholas in March 2016.Hes just as bad as a drug dealer on the street," she said after the sentencing. "He's actually worse. The biggest thing is that even after being sentenced, he couldn't look over to us and apologize to me and my mom.
|
|
Interventional Pain Management Reports
is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine.
Interventional Pain Management Reports
is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of
Pain Physician
.
Interventional Pain Management Reports Interventional Pain Management Reports
is an open access journal, available online with free full manuscripts.
The benefits of publishing in an open access journal that has a corresponding
print edition journal are:
- Your article will have the potential to obtain more citations.
- Your article will be peer-reviewed and published faster than other journals.
- Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.
- Open Access journals are FREE to view, download and to print.
So submit today your:
- Case Reports
- Technical Reports
- Editorials
- Short Perspectives
|
|
Pharmaceutical Company Agrees to Pay $17.5 Million to Resolve Allegations of Kickbacks to Medicare Patients and Physicians
The Justice Department announced today that US WorldMeds LLC (USWM) has agreed to pay $17.5 million to resolve allegations that it violated the False Claims Act, 31 U.S.C. §§ 3729
et seq
., by paying kickbacks to patients and physicians to improperly induce prescriptions of its drugs, Apokyn® and Myobloc®. USWM is a pharmaceutical manufacturer headquartered in Louisville, Kentucky.
“The Department of Justice is committed to ensuring that physicians’ and patients’ selection of medications is not influenced by improper financial considerations,” said Assistant Attorney General Jody Hunt of the Department of Justice’s Civil Division. “The nation’s health care programs and taxpayers deserve health care companies that play by the rules, including the Anti-Kickback Statute.”
|
|
2019 MIPS Reporting? Start Now.
MIPS-eligible clinicians must report a full year of data. Don’t fall behind – keep up with NIPM-QCDR.
MIPS 2019 has brought larger payment adjustments and greater reporting requirements, including a 365-day performance period for the Quality and Cost categories. The sooner you start your MIPS reporting for 2019, the better.
Sign up today to use ASIPP’s NIPM-QCDR for MIPS.
This powerful tool makes MIPS reporting easy through the use of our new patient-reported outcomes measures for 2019, which ease the burden on providers and reduces costly EMR integration.
|
|
Pain Physician
March/April 2019 Issue Features
Systematic Review
Ian D. Coulter, PhD, Cindy Crawford, BA, Howard Vernon, DC. PhD, Eric L. Hurwitz, DC. PhD, Raheleh Khorsan, PhD, Marika Suttorp Booth, MS, and Patricia M. Herman, ND, PhD
Systematic Review
Nitika Sanger, HBSc, Meha Bhatt, MSc, Nikhita Singhal, BHSc, Katherine Ramsden, MD, Natasha Baptist-Mohseni, BSc, Balpreet Panesar, BSc, Hamnah Shahid, BASc, Alannah Hillmer, BSc, Alessia D'Elia, BSc, Candice Luo, BHSc, Victoria Rogers, BSc, Abirami Arunan, HBSc, Lola Baker-Beal, BSc, Sean Haber, BSc, Jihane Henni, BSc, Megan Puckering, BSc, Sunny Sun, BSc, Kim Ng, BSc, Stephanie Sanger, MLIS, Natalia Mouravaska, MD, M. Constantine Samaan, MD, Russell de Souza, ScD, Lehana Thabane, PhD, and Zainab Samaan, PhD
Randomized Trial
Doo-Hwan Kim, MD, Myung-Su Lee, MD, Sookyung Lee, MD, Syn-Hae Yoon, MD, Jin-Woo Shin, MD, PhD, and Seong-Soo Choi, MD, PhD
Randomized Controlled Trial
Neerja Bharti, MD, John Sujith, MD, Navneet Singla, Mch, Nidhi B. Panda, MD, and Indu Bala, MD.
|
|
HHS announces final rule requiring drug pricing to be included on television advertising
The Office of Intergovernmental and External Affairs in the Department of Health and Human Services (HHS) recently issued a final rule requiring drug manufacturers to include their list price in television advertisements for prescription pharmaceuticals covered by Medicare or Medicaid. The rule is expected to appear in the Federal Register later this week and the compliance date will be 60 days from date of that publication. The new rule (42 CFR § 403.1202) requires that advertisements for Medicare or Medicaid covered prescription drugs or biological products on television (including broadcast, cable, streaming, and satellite) contain a statement indicating the Wholesale Acquisition Cost (referred to as WAC or the list price) for a typical 30-day regimen or for a typical course of treatment, whichever is most appropriate if such a 30 day supply costs more than $35. Please see the following links to view the final rule, an HHS press release and an HHS fact sheet about the new rule.
|
|
July 12-14, 2019
GSIPP 2019 - 15th Annual Meeting & Pain Summit
The Cloister Hotel at Sea Island
Sea Island, GA
July 26-28, 2019
PAIN 2019
West Virginia Society of Pain Physicians
Loews Miami Beach, FL
|
|
|
|
|
|
|
